Vol 2, No 4 (2011)
Review paper
Published online: 2011-12-28
Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation
Hematologia 2011;2(4):326-331.
Abstract
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular
activation of coagulation, leading to widespread deposition of fibrin in the circulation.
The fibrin deposition contributes to multiple organ failure. The massive and ongoing
activation of coagulation may result in depletion of platelets, fibrinogen and other coagulation
factors, which may cause bleeding (consumption coagulopathy). Disseminated intravascular
coagulation is not a disease in itself but is a complication of a variety of disorders and clinical
conditions. There is no single lab test sufficiently accurate to establish or reject a diagnosis of
DIC. However, a combination of widely available haemostatic lab tests, may be helpful in
making the diagnosis of DIC, according to a recently developed algorithm. The cornerstone of
the treatment of DIC is the specific and vigorous treatment of the underlying disorder. Other
therapeutic strategies comprise blood components replacement therapy, inhibition of coagulation
activation (heparin, activated protein C) and — very rarely — antifibrinolytics.
Hematologia 2011; 2, 4: 326–331
Hematologia 2011; 2, 4: 326–331
Keywords: DICheparinreplacementcoagulation testsD-dimerantithrombinprotein Cantifibrynolyticsblood components
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)